ArticleJournal of public health policy2012
Lessons from SARS and H1N1/A: employing a WHO-WTO forum to promote optimal economic-public health pandemic response.
Article in Journal of public health policy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- A national framework for managing dual-use research of concern: integrating biosecurity, public health, and research governance.Frontiers in bioengineering and biotechnology · 2026Article
- From isolation to revival: trade recovery amid global health crises.Globalization and health · 2024Article
- A computational stochastic procedure for solving the epidemic breathing transmission system.Scientific reports · 2023Article
- Early Stage Risk Identification and Governance of Major Emerging Infectious Diseases: A Double-Case Study Based on the Chinese Context.Risk management and healthcare policy · 2023Article
- Influence of COVID-19 on the Tourism Industry in China: An Artificial Neural Networks Approach.Journal of healthcare engineering · 2022Article
- Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans.Frontiers in pharmacology · 2022Article
- Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients.Frontiers in public health · 2022Observational
- Entrepreneurship during a pandemic.European journal of law and economics · 2022Article
- Bad law or implementation flaws? Lessons from the implementation of the new law on epidemics during the response to the first wave of COVID-19 in Switzerland.Health policy (Amsterdam, Netherlands) · 2021Article
- A qualitative enquiry into strategic and operational responses to Covid-19 challenges in South Asia.Journal of public affairs · 2020Article
- Impacts of COVID-19 on global tourism industry: A cross-regional comparison.Tourism management perspectives · 2020Article
- Implications of human activities for (re)emerging infectious diseases, including COVID-19.Journal of physiological anthropology · 2020Review
- Short report on implications of Covid-19 and emerging zoonotic infectious diseases for pastoralists and Africa.Pastoralism : research, policy and practice · 2020Article
- Concealing Disease: Trade and Travel Barriers and the Timeliness of Outbreak Reporting.International studies perspectives · 2019Article
- Article
- Domestic politics and the WHO's International Health Regulations: Explaining the use of trade and travel barriers during disease outbreaks.The review of international organizations · 2017Article
- The Ebola Outbreak: Catalyzing a "Shift" in Global Health Governance?BMC infectious diseases · 2016Article
- Promoting public health legal preparedness for emergencies: review of current trends and their relevance in light of the Ebola crisis.Global health action · 2015Review
- Responding to the public health consequences of the Ukraine crisis: an opportunity for global health diplomacy.Journal of the International AIDS Society · 2015Article
- Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Clinical microbiology reviews · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
No formal system exists to review trade restrictions imposed during international public health emergencies rapidly. Failure to put one in place creates disincentives for surveillance and reporting, thereby undermining protection efforts. The 2003 SARS outbreak exposed weaknesses in global governance that caused uncoordinated public health and economic responses. New International Health Regulations (IHR), applied first during the 2009 H1N1 influenza outbreak, demonstrated improvement. Yet they failed to allow for management of public health emergencies in a way that balanced threats to health and those to economies and trade. Establishment of a joint WHO-WTO committee to adjudicate these conflicts might better achieve that balance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.